[Acute phosphate nephropathy after the use of sodium phosphate preparation].
Connor
A
A
Department of Renal Medicine, Dorset County Hospital, Dorchester DT1 2JY. andrewconnor1974@hotmail.ca.uk
Sykes
L
L
Roberts
I S D
IS
Weston
C E
CE
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001706:Biopsy; D002400:Cathartics / Q000009:adverse effects*; D003113:Colonoscopy; D003404:Creatinine / Q000097:blood; D004733:Enema / Q000009:adverse effects*; D004921:Erythropoietin / Q000627:therapeutic use; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D007668:Kidney / Q000473:pathology; D009397:Nephrocalcinosis / Q000473:pathology; D010710:Phosphates / Q000009:adverse effects*; D011239:Prednisolone / Q000627:therapeutic use; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D002400:Cathartics; D010710:Phosphates; D004921:Erythropoietin; D011239:Prednisolone; D003404:Creatinine; C018279:sodium phosphate